The potential of pamrevlumab in diseases with underlying mechanisms of fibrotic processes and its prospects in ophthalmology
Introduction: Pamrevlumab, a monoclonal antibody targeting CTGF, is considered a potential therapy for eye diseases involving fibrosis. The aim of this study was to explore its potential in treating eye diseases. Methods: A systematic review was conducted following PRISMA guidelines, searc...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Pensoft Publishers
2025-06-01
|
| Series: | Pharmacia |
| Online Access: | https://pharmacia.pensoft.net/article/144964/download/pdf/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849428789149302784 |
|---|---|
| author | Lely Retno Wulandari Edwin Damar Prabowo Happy Kurnia Permata Sari Hidayat Sujuti Sri Winarsih |
| author_facet | Lely Retno Wulandari Edwin Damar Prabowo Happy Kurnia Permata Sari Hidayat Sujuti Sri Winarsih |
| author_sort | Lely Retno Wulandari |
| collection | DOAJ |
| description | Introduction: Pamrevlumab, a monoclonal antibody targeting CTGF, is considered a potential therapy for eye diseases involving fibrosis. The aim of this study was to explore its potential in treating eye diseases. Methods: A systematic review was conducted following PRISMA guidelines, searching studies up to 2024 across various databases. Study quality was assessed using the Cochrane RoB 2.0 tool. Results: Pamrevlumab has the potential to slow fibrosis progression and improve organ function, although treatment responses varied. Two studies showed significant changes, while four did not. The risk of bias indicated varied methodological quality. Discussion: Pamrevlumab shows potential in treating fibrosis-related eye diseases by inhibiting CTGF. Further research is needed to assess its long-term effects, safety, and dose optimization. Conclusion: Pamrevlumab shows significant potential in the treatment of chronic eye diseases, with promising safety outcomes based on previous experiences in DMD patients. |
| format | Article |
| id | doaj-art-1fd29e1f766e4eb4ae1641744e7d2445 |
| institution | Kabale University |
| issn | 2603-557X |
| language | English |
| publishDate | 2025-06-01 |
| publisher | Pensoft Publishers |
| record_format | Article |
| series | Pharmacia |
| spelling | doaj-art-1fd29e1f766e4eb4ae1641744e7d24452025-08-20T03:28:34ZengPensoft PublishersPharmacia2603-557X2025-06-017211010.3897/pharmacia.72.e144964144964The potential of pamrevlumab in diseases with underlying mechanisms of fibrotic processes and its prospects in ophthalmologyLely Retno Wulandari0Edwin Damar Prabowo1Happy Kurnia Permata Sari2Hidayat Sujuti3Sri Winarsih4Universitas BrawijayaUniversitas BrawijayaUniversitas BrawijayaUniversitas BrawijayaUniversitas BrawijayaIntroduction: Pamrevlumab, a monoclonal antibody targeting CTGF, is considered a potential therapy for eye diseases involving fibrosis. The aim of this study was to explore its potential in treating eye diseases. Methods: A systematic review was conducted following PRISMA guidelines, searching studies up to 2024 across various databases. Study quality was assessed using the Cochrane RoB 2.0 tool. Results: Pamrevlumab has the potential to slow fibrosis progression and improve organ function, although treatment responses varied. Two studies showed significant changes, while four did not. The risk of bias indicated varied methodological quality. Discussion: Pamrevlumab shows potential in treating fibrosis-related eye diseases by inhibiting CTGF. Further research is needed to assess its long-term effects, safety, and dose optimization. Conclusion: Pamrevlumab shows significant potential in the treatment of chronic eye diseases, with promising safety outcomes based on previous experiences in DMD patients.https://pharmacia.pensoft.net/article/144964/download/pdf/ |
| spellingShingle | Lely Retno Wulandari Edwin Damar Prabowo Happy Kurnia Permata Sari Hidayat Sujuti Sri Winarsih The potential of pamrevlumab in diseases with underlying mechanisms of fibrotic processes and its prospects in ophthalmology Pharmacia |
| title | The potential of pamrevlumab in diseases with underlying mechanisms of fibrotic processes and its prospects in ophthalmology |
| title_full | The potential of pamrevlumab in diseases with underlying mechanisms of fibrotic processes and its prospects in ophthalmology |
| title_fullStr | The potential of pamrevlumab in diseases with underlying mechanisms of fibrotic processes and its prospects in ophthalmology |
| title_full_unstemmed | The potential of pamrevlumab in diseases with underlying mechanisms of fibrotic processes and its prospects in ophthalmology |
| title_short | The potential of pamrevlumab in diseases with underlying mechanisms of fibrotic processes and its prospects in ophthalmology |
| title_sort | potential of pamrevlumab in diseases with underlying mechanisms of fibrotic processes and its prospects in ophthalmology |
| url | https://pharmacia.pensoft.net/article/144964/download/pdf/ |
| work_keys_str_mv | AT lelyretnowulandari thepotentialofpamrevlumabindiseaseswithunderlyingmechanismsoffibroticprocessesanditsprospectsinophthalmology AT edwindamarprabowo thepotentialofpamrevlumabindiseaseswithunderlyingmechanismsoffibroticprocessesanditsprospectsinophthalmology AT happykurniapermatasari thepotentialofpamrevlumabindiseaseswithunderlyingmechanismsoffibroticprocessesanditsprospectsinophthalmology AT hidayatsujuti thepotentialofpamrevlumabindiseaseswithunderlyingmechanismsoffibroticprocessesanditsprospectsinophthalmology AT sriwinarsih thepotentialofpamrevlumabindiseaseswithunderlyingmechanismsoffibroticprocessesanditsprospectsinophthalmology AT lelyretnowulandari potentialofpamrevlumabindiseaseswithunderlyingmechanismsoffibroticprocessesanditsprospectsinophthalmology AT edwindamarprabowo potentialofpamrevlumabindiseaseswithunderlyingmechanismsoffibroticprocessesanditsprospectsinophthalmology AT happykurniapermatasari potentialofpamrevlumabindiseaseswithunderlyingmechanismsoffibroticprocessesanditsprospectsinophthalmology AT hidayatsujuti potentialofpamrevlumabindiseaseswithunderlyingmechanismsoffibroticprocessesanditsprospectsinophthalmology AT sriwinarsih potentialofpamrevlumabindiseaseswithunderlyingmechanismsoffibroticprocessesanditsprospectsinophthalmology |